JP2024527175A5 - - Google Patents
Info
- Publication number
- JP2024527175A5 JP2024527175A5 JP2023543464A JP2023543464A JP2024527175A5 JP 2024527175 A5 JP2024527175 A5 JP 2024527175A5 JP 2023543464 A JP2023543464 A JP 2023543464A JP 2023543464 A JP2023543464 A JP 2023543464A JP 2024527175 A5 JP2024527175 A5 JP 2024527175A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- score
- combination
- kpps
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2021/050001 WO2022158991A1 (en) | 2021-01-20 | 2021-01-20 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
| PTPCT/PT2021/050001 | 2021-01-20 | ||
| PCT/PT2021/050026 WO2022158992A1 (en) | 2021-01-20 | 2021-08-04 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527175A JP2024527175A (ja) | 2024-07-22 |
| JP2024527175A5 true JP2024527175A5 (https=) | 2024-07-29 |
Family
ID=74494985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543464A Pending JP2024527175A (ja) | 2021-01-20 | 2021-08-04 | レボドパと組み合わせるオピカポンを用いたパーキンソン病に関連する疼痛の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240066015A1 (https=) |
| EP (1) | EP4281071A1 (https=) |
| JP (1) | JP2024527175A (https=) |
| CN (1) | CN116963735A (https=) |
| WO (2) | WO2022158991A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020072886A1 (en) | 2018-10-05 | 2020-04-09 | Neurocrine Biosciences, Inc. | Methods for the administration of comt inhibitors |
| EP4360627A1 (fr) * | 2022-10-26 | 2024-05-01 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Traitement de l'arthrose par des inhibiteurs de comt |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20000635A0 (fi) * | 2000-03-17 | 2000-03-17 | Orion Yhtymae Oyj | COMT-inhibiittoreiden käyttö analgeettina |
| JP5435165B2 (ja) * | 2012-05-31 | 2014-03-05 | 小野薬品工業株式会社 | 医薬用途 |
| JP6622310B2 (ja) * | 2014-09-04 | 2019-12-18 | ロブソル・ファーマシューティカルズ・アクチボラグＬｏｂｓｏｒ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ａｋｔｉｅｂｏｌａｇ | レボドパ、ドーパミン脱炭酸酵素阻害薬およびｃｏｍｔ阻害薬を含む医薬組成物ならびにその投与方法 |
| RU2017120184A (ru) * | 2014-11-28 | 2018-12-28 | БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. | Лекарства для замедления течения болезни паркинсона |
| MX383906B (es) * | 2015-10-09 | 2025-03-14 | Teva Pharmaceuticals Int Gmbh | Combinación de levodopa deuterado con carbidopa y opicapona para el tratamiento del mal de parkinson |
| EP4262798A1 (en) * | 2020-12-17 | 2023-10-25 | Bial-Portela & CA, S.A. | Treatment regimens for early idiopathic parkinson's disease |
-
2021
- 2021-01-20 WO PCT/PT2021/050001 patent/WO2022158991A1/en not_active Ceased
- 2021-08-04 EP EP21752278.8A patent/EP4281071A1/en active Pending
- 2021-08-04 US US18/273,515 patent/US20240066015A1/en active Pending
- 2021-08-04 CN CN202180095156.0A patent/CN116963735A/zh active Pending
- 2021-08-04 WO PCT/PT2021/050026 patent/WO2022158992A1/en not_active Ceased
- 2021-08-04 JP JP2023543464A patent/JP2024527175A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009511618A (ja) | 中度から重度のむずむず脚症候群（ｒｌｓ）を治療するためのプラミペキソールの使用 | |
| JP2009508854A (ja) | 睡眠時呼吸障害の予防及び治療方法及び手段 | |
| ES2313330T3 (es) | Derivados de alfa-aminoamida utiles en el tratamiento del sindrome de piernas inquietas. | |
| JP2024527175A5 (https=) | ||
| Factor et al. | Emergency department presentations of patients with Parkinson's disease | |
| JP2024534427A5 (https=) | ||
| JP2023546140A5 (https=) | ||
| JP2023545372A5 (https=) | ||
| CN115697386A (zh) | 一种治疗帕金森病的方法和药物 | |
| CY1111783T1 (el) | Θεραπεια συνδυασμου διαταραχων κατωτερης ουροποιητικης οδου με 2 προσδεματα και μη στεροειδες αντιφλεγμονωδες φαρμακο | |
| JP5403935B2 (ja) | 経口用の慢性疼痛予防または治療剤 | |
| US6855735B2 (en) | Ketamine treatment of restless legs syndrome | |
| JP2016505050A5 (https=) | ||
| JP2011121975A (ja) | 線維筋痛症に伴う疼痛を改善するための線維筋痛症に伴う疼痛改善用医薬組成物 | |
| Obering et al. | Update on apomorphine for the rapid treatment of hypomobility (“off”) episodes in Parkinson's disease | |
| US20050095278A1 (en) | Use of nitroglycerin to relieve nocturnal muscle cramps | |
| JP2014530249A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| Yu et al. | Creatine derivatives: rapid complete relief of pain by topical or transcutaneous administration | |
| JP2024505212A5 (https=) | ||
| JP5163986B2 (ja) | フェニル酪酸ナトリウムを使用する、薬物依存症又はアルコール依存症或いは躁うつ病の予防又は治療のための医薬組成物 | |
| JP2022543598A5 (https=) | ||
| JPS6187621A (ja) | アレルギ−性鼻炎及びアレルギ−性喘息治療薬 | |
| JP7312286B2 (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| Hatipoğlu et al. | Symptomatic Agents for Pediatric Ear, Nose, and Throat Infections |